solutions

Chapter 58 - The Shadow of the Pharma Giant

The peace of the new family unit was tested four months later when spring brought an unexpected international challenge to Bellmont.

St. Catherine’s Hayes Trauma Center had partnered with the St. Gabriel Institute to develop an open-source, low-cost generic formulation of a pediatric respiratory surfactant—a life-saving lung lubricant required by premature infants born with respiratory distress syndrome. Commercial pharmaceutical companies charged over four thousand dollars per vial, forcing public rural hospitals to ration the medication.

Emma’s research team, headed by Dr. Chen, had developed an identical bio-synthetic compound that could be produced locally for forty dollars per dose.

The threat to big pharma profits was immediate and catastrophic.

On a warm Monday morning in April, an international healthcare conglomerate named Valence Pharmaceuticals, based out of Zurich, filed an emergency intellectual property infringement claim in Federal District Court, demanding the immediate seizure of all St. Catherine’s research servers, synthetic culture vats, and clinical notes.

Leading the charge was Dr. Viktor Brandt—a brilliant, unscrupulous Swiss biochemist who had made a fortune patenting proprietary modifications to public medical research.

Brandt didn't just file legal papers. He flew to Bellmont on a private Gulfstream jet, checking into the luxury suite at the Riverfront Grand Hotel, flanked by six private European corporate security guards.

At 2:00 p.m., Brandt walked into Emma’s administrative office unannounced.

He was fifty-five, impeccably groomed, with slicked silver hair, gold-rimmed spectacles, and an aroma of expensive cologne that couldn't mask the arrogance in his demeanor.

“Director Emma Hayes Cross,” Brandt said, offering a stiff, theatrical bow. “I am Dr. Viktor Brandt, Chief Executive of Valence Pharmaceuticals. I came to offer you a very generous compromise before my legal teams dismantle your little research project.”

Emma remained seated, her hands folded neatly over her desk blotter, her expression as cool and clinical as surgical steel. “You have three minutes, Dr. Brandt. Before my security escorts you off hospital property.”

Brandt chuckled softly, sitting down uninvited. “Valence Pharmaceuticals holds thirty-two patents on modified bovine pulmonary lipid fractions. Your little synthetic surfactant uses a molecular peptide chain that our lab patented in Bern six years ago. When my federal injunction takes effect on Friday, St. Catherine’s will be hit with a three-hundred-million-dollar patent infringement judgment.”

“Your patent is invalid, Dr. Brandt,” Emma countered smoothly. “The peptide chain in question was published in an open-access medical journal by researchers at Oxford University in 2008—four years before your company filed its secondary patent. You filed a frivolous 'evergreening' claim to lock out generic competitors and keep premature infants dying in underfunded hospitals.”

Brandt’s eyes narrowed into cold, vicious slits. “The law doesn't care about dying babies, Mrs. Cross. The law cares about capital investments and registered patent numbers. But I am a reasonable man. Valence will purchase your generic synthesis data for twenty million dollars. We will brand it, distribute it globally at three thousand dollars per vial, and give St. Catherine’s a two-percent royalty.”

Emma stood up, her blue eyes flashing with a righteous, lethal fury that made Brandt flinch backward against his chair.

“You will never put a price tag on our medicine, Dr. Brandt,” Emma said, her voice dropping into a register of pure, unbreakable authority. “You take your twenty million dollars, your fraudulent Swiss patents, and your corporate thugs, and you get out of my hospital. If you think you can profit off the suffocation of premature children, you have picked the wrong city to rob.”

Brandt sneered, standing up and straightening his silk tie. “You have until Friday, Director. If you do not sign the licensing surrender, Valence will purchase every mortgage bond on this hospital’s expansion and call the debt due within twenty-four hours. Let us see how many premature babies you can save when the bulldozers arrive.”

Brandt turned and stormed out of the office.

May you like

Emma didn't panic. She picked up her desk phone, tapped extension 101, and said three simple words:

“Marco. Bring Julian.”

Related Stories

Other posts